Northwestern Mutual Wealth Management’s MiNK Therapeutics INKT Stock Holding History
Bought
Maintained
Sold
Other funds holding INKT
VCM
LF
VFT
SPIA
PP
AGWCA
TRCT
Northwestern Mutual Wealth Management's INKT Position: Q1 2026 in Review
Northwestern Mutual Wealth Management held its MiNK Therapeutics (INKT) position steady in Q1 2026 at 18 shares worth $190. The position accounts for ﹤0.01% of the portfolio, ranked #3945.
Northwestern Mutual Wealth Management first reported a position in INKT in Q2 2023 and has held it in 12 quarters since. The position peaked at $389 in Q2 2023. 23 funds tracked by Wall St. Rank hold INKT as of Q1 2026.
- Northwestern Mutual Wealth Management held 18 shares of MiNK Therapeutics worth $190 as of Q1 2026.
- Northwestern Mutual Wealth Management left its MiNK Therapeutics share count unchanged in Q1 2026.
- MiNK Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q1 2026, its #3945 holding.
- Northwestern Mutual Wealth Management first reported a position in MiNK Therapeutics in Q2 2023 and has held it in 12 quarters since.
- Northwestern Mutual Wealth Management's MiNK Therapeutics position peaked at $389 in Q2 2023.
- 23 funds tracked by Wall St. Rank held MiNK Therapeutics as of Q1 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.